This cohort study investigates whether there are substantial differences in mortality rates for patients with ischemic heart disease and chronic heart failure who received care at Department of Veterans Affairs medical centers.
This study estimates the potential association of the 2017 and 2014 hypertension guideline treatment goals with the proportion of US adults defined as being hypertensive or recommended for antihypertensive treatment.
This cohort study uses participant data from the Japan Morning Surge–Home Blood Pressure study to examine the association between hypertension defined by a home blood pressure device and the risk for stroke and other adverse cardiovascular outcomes.
This cohort study provides contemporary estimates of sudden and/or arrhythmic death vs other competing causes of death in patients with coronary heart disease without severe systolic dysfunction to search for high-risk subgroups that might be targeted in future trials of prevention of sudden and/or arrhythmic death.
This cohort study analyzes the association between the burden of atrial fibrillation on 14-day noninvasive, continuous electrocardiographic monitoring and the rate of thromboembolism among adults with paroxysmal atrial fibrillation while not taking anticoagulation.
This difference-in-differences study examines whether reducing malpractice risk is associated with clinical decisions involving coronary artery disease testing and treatment.
This mendelian randomization analysis estimates the magnitude of the change in plasma lipoprotein(a) levels needed to have the same evidence of an association with coronary heart disease risk as a 38.67-mg/dL change in low-density lipoprotein cholesterol level.
This survey assesses how public reporting of percutaneous coronary intervention outcomes influences clinical decision making among interventional cardiologists in Massachusetts and New York.
This Viewpoint discusses the frequency of plaque dislodgement and embolization in 2 contrasting approaches to left-sided cardiac catherization.
This From the Heart describes a patient with fibrosis who remained her primary advocate through her end of life.
This special communication examines the challenges, opportunities, and alternatives surrounding public reporting programs for percutaneous coronary intervention outcomes in the United States.
This narrative review provides an overview of the epidemiology, pathogenesis, diagnosis, prevention, and treatment of left ventricular thrombus after acute myocardial infarction and offers guidance regarding a practical antithrombotic approach in this setting.
This review summarizes the history, considerations for use, and future direction of left ventricular assist device therapy for advanced heart failure.
A 40-year-old man who smoked with a self-described heart valve problem and several days of flulike symptoms presented to the emergency department with acute onset of palpitations and diaphoresis. What would you do next?
This synopsis of the 2017 Amercian Heart Association/American College of Cardiology Clinical Performance and Quality Measures for Adults with ST-Elevation and Non–ST-Elevation Myocardial Infarction discusses new guidelines for treatment of patients with ST-elevation and non–ST-elevation myocardial infarction.
Create a personal account or sign in to: